|
1）Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. Study of 14 patients. Arch Neurol. 2001; 58: 225-30
|
|
|
|
2）Saiz A, Blanco Y, Sabater L. Spectrum of neuro-logical syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008; 131(Pt 10): 2553-63
|
|
|
|
|
|
3）Nanri K, Niwa H, Mitoma H, ea al. Low-titer anti-GAD-antibody-positive cerebellar ataxia. Cerebellum. 2012. In press
|
|
|
|
|
|
4）Bushara KO, Goebel SU, Shill H, et al. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol. 2001; 49: 540-3
|
|
|
|
|
|
5）Hadjivassiliou M, Sanders DS, Woodroofe N, et al. Gluten ataxia. Cerebellum. 2008; 7: 494-8
|
|
|
|
|
|
6）Burk K, Wick M, Roth G, et al. Antineuronal antibodies in sporadic late-onset cerebellar ataxia. J Neurol. 2010; 257: 59-62
|
|
|
|
|
|
7）Fancellu R, Pareyson D, Corsini E, et al. Immunological reactivity against neuronal and non-neuronal antigens in sporadic adult-onset cerebellar ataxia. Eur Neurol. 2009; 62: 356-61
|
|
|
|
|
|
8）Shaw PJ, Walls TJ, Newman PK, et al. Hashimotos encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers - report of 5 cases. Neurology. 1991; 41: 228-33
|
|
|
|
|
|
9）Chaudhuri A, Behan PO. The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimotos encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem. 2003; 10: 1945-53
|
|
|
|
|
|
10）Ferracci F, Bertiato G, Moretto G, et al. Hashimotos encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci. 2004; 217: 165-8
|
|
|
|
|
|
11）Peschen-Rosin R, Schabet M, Dichgans J, et al. Manifestation of Hashimotos encephalopathy years before onset of thyroid disease. Eur Neurol. 1999; 41: 79-84
|
|
|
|
|
|
12）Fujii A, Yoneda M, Ito T, et al. Autoantibodies against the amino terminal of α-enolase are a useful diagnostic marker of Hashimotos encepha-lopathy. J Neuroimmunol. 2005; 162: 130-6
|
|
|
|
|
|
13）Yoneda M, Fujii A, Ito A, et al. High prevalence of serum autoantibodies against the amino ter-minal of α-enolase in Hashimotos encephalo-pathy. J Neuroimmunol. 2007; 185: 195-200
|
|
|
|
|
|
14）松永晶子，米田 誠．抗N末端αエノラーゼ抗体陽性橋本脳症．臨床病理. 2009; 57: 271-8
|
|
|
|
|
|
15）Zuliani L, Sabater L, Saiz A, et al. Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia. Neurology. 2007; 68: 239-40
|
|
|
|
|
|
16）Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol. 2010; 257: 509-17
|
|
|
|
|
|
17）Uchibori A, Sakuta M, Kusunoki S, et al. Auto-antibodies in postinfectious acute cerebellar ataxia. Neurology. 2005; 65: 1114-6
|
|
|
|
|
|
18）Jarius S, Wandinger KP, Horn S, et al. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization. J Neuroinflammation. 2010; 7: 21
|
|
|
|
|
|
19）Mitoma H, Song SY, Ishida K. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci. 2000; 175: 40-4
|
|
|
|
|
|
20）Ishida K, Mitoma H, Mizusawa H. Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies. J Neurol Sci. 2008; 271: 186-90
|
|
|
|
|
|
21）Nakagawa H, Yoneda M, Fujii A, et al. Hashimotos encephalopathy presenting with progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2007; 78: 196-7
|
|
|
|
|
|
22）Matsunaga A, Ikawa M, Fujii A, et al. Hashimotos encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration. Eur Neurol. 2012. In press
|
|
|
|
|
|
23）山本幹枝，和田健司，米田 誠，他．抗N末端α-エノラーゼ抗体をみとめた急性小脳失調症の1例．臨床神経. 2010; 50: 581-4
|
|
|
|
|
24）Nanri K, Okita M, Takeguchi M, et al. Intravenous immunoglobulin therapy for auto-antibody-positive cerebellar ataxia. Intern Med. 2009; 48: 783-90
|
|
|
|
|
|
25）田中伸幸，大獄宏明，伊藤 傑，他．免疫グロブリン治療が奏功した罹病期間16年の抗TPO抗体・抗グリアジン抗体陽性小脳萎縮症の1例．臨床神経. 2012; 52: 351-5
|
|
|
|
|
|
26）Tang Y, Chu C, Lin MT, et al. Hashimotos encephalopathy mimicking spinocerebellar ataxia. J Neurol. 2011; 258: 1705-7
|
|
|
|
|